XORTX Therapeutics Inc. (XRTX) income statement
XRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.84−0.05 (-5.73%)
Close on Nov 20, 2026Market cap $91.95KP/E –Yield –
XORTX Therapeutics Inc. financial ratios
See a number that looks wrong?